From the Journals

U.S. cancer death rates drop for second year in a row


 

Increase in incidence at common sites

Despite the steady progress in mortality for most cancers, “rates continue to increase for some common sites,” Ms. Siegel and colleagues reported.

For example, death rates from uterine corpus cancer have accelerated from the late 1990s at twice the pace of the increase in its incidence. Death rates also have increased for cancers of the oral cavity and pharynx – although in this cancer, increases in mortality parallel an increase in its incidence.

Pancreatic cancer death rates [in turn] continued to increase slowly in men ... but remained stable in women, despite incidence [rates] rising by about 1% per year in both sexes,” the authors observed.

Meanwhile, the incidence of cervical cancer, although declining for decades overall, is increasing for patients who present with more distant-stage disease as well as cervical adenocarcinoma, both of which are often undetected by cytology.

“These findings underscore the need for more targeted efforts to increase both HPV [human papillomavirus] vaccination among all individuals aged [26 and younger] and primary HPV testing or HPV/cytology co-testing every 5 years among women beginning at age 25,” the authors emphasized.

On a more positive note, the long-term increase in mortality from liver cancer has recently slowed among women and has stabilized among men, they added.

Once again, disparities in both cancer occurrence and outcomes varied considerably between racial and ethnic groups. For example, cancer is the leading cause of death in people who are Hispanic, Asian American, and Alaska Native. Survival rates at 5 years for almost all cancers are still higher for White patients than for Black patients, although the disparity in cancer mortality between Black persons and White persons has declined to 13% from a peak of 33% in 1993.

Geographic disparities in cancer mortality rates still prevail; the rates are largest for preventable cancers such as lung and cervical cancer, for which mortality varies by as much as fivefold across states.

And although cancer remains the second most common cause of death among children, death rates from cancer have continuously declined over time among both children and adolescents, largely the result of dramatic declines in death rates from leukemia in both age groups.

The study authors have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

National lung cancer screening guidelines may miss younger African American individuals at high risk
Journal of Clinical Outcomes Management
Real-world results with checkpoint inhibitors found inferior to trial results
Journal of Clinical Outcomes Management
New cancer drugs may have saved more than 1.2 million Americans
Journal of Clinical Outcomes Management
‘Test all patients with cancer’: One in eight have inherited mutations
Journal of Clinical Outcomes Management
Using telehealth to deliver palliative care to cancer patients
Journal of Clinical Outcomes Management
50.6 million tobacco users are not a homogeneous group
Journal of Clinical Outcomes Management
Reduced cancer mortality with Medicaid expansion
Journal of Clinical Outcomes Management
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Journal of Clinical Outcomes Management
Cancer rates on the rise in adolescents and young adults
Journal of Clinical Outcomes Management
FDA OKs osimertinib as first adjuvant drug for NSCLC
Journal of Clinical Outcomes Management